NeoGenomics, Inc. (NEO) financial statements (2022 and earlier)

Company profile

Business Address 9490 NEOGENOMICS WAY
FORT MYERS, FL 33912
State of Incorp. NV
Fiscal Year End December 31
SIC 8734 - Testing Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments515543572803296284295
Cash and cash equivalents317341369612229233295
Short-term investments1992022031916850 
Receivables11210510610310710488
Inventory, net of allowances, customer advances and progress billings23222121302122
Inventory23222121302122
Prepaid expense1215141112108
Assets held-for-sale, not part of disposal group1010     
Other current assets81685546
Total current assets:682710722943449422419
Noncurrent Assets
Operating lease, right-of-use asset1021025551464648
Property, plant and equipment10910711294868584
Long-term investments and receivables   10  13
Long-term investments      13
Due from related parties   10   
Intangible assets, net (including goodwill)969977971329332334337
Goodwill527526500211211211211
Intangible assets, net (excluding goodwill)442451471118121123126
Contract with customer, asset, net  00000
Capitalized contract cost, net  11111
Restricted cash and investments 3411223236
Other noncurrent assets7785543
Other undisclosed noncurrent assets  244949355
Total noncurrent assets:1,1881,1961,175552540537526
TOTAL ASSETS:1,8701,9061,8961,494988959945
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities56616243504441
Accounts payable18292319251819
Employee-related liabilities38323924252622
Deferred revenue5544444
Debt1222344
Other undisclosed current liabilities25253119171312
Total current liabilities:87939968736562
Noncurrent Liabilities
Long-term debt and lease obligation, including:533532532531169168166
Long-term debt, excluding current maturities532532531530168166165
Finance lease, liability0001112
Operating lease, liability72725046424345
Other undisclosed long-term debt and lease obligation(72)(72)(50)(46)(42)(43)(45)
Liabilities, other than long-term debt7073686101819
Deferred revenue1111111
Deferred income tax liabilities555864251415
Other liabilities141444443
Other undisclosed noncurrent liabilities71714946424244
Total noncurrent liabilities:674676649583221228230
Total liabilities:762769748651294293291
Stockholders' equity
Stockholders' equity attributable to parent, including:1,1081,1371,148844694666654
Additional paid in capital1,1241,1111,101872701689679
Accumulated other comprehensive income (loss)(1)(0)(0)(0)000
Retained earnings (accumulated deficit)(15)2747(29)(7)(23)(25)
Other undisclosed stockholders' equity attributable to parent0000000
Total stockholders' equity:1,1081,1371,148844694666654
TOTAL LIABILITIES AND EQUITY:1,8701,9061,8961,494988959945

Income statement (P&L) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues12612112211612612587
Cost of revenue
(Cost of Goods and Services Sold)
(80)(74)(69)(74)(69)(71)(59)
Gross profit:45475342575428
Operating expenses(87)(87)(75)(57)(52)(49)(47)
Operating income (loss):(42)(40)(22)(15)65(19)
Nonoperating income (expense)(110)1897(5)407
Investment income, nonoperating 1897    
Other nonoperating income (expense) 00(5)407
Interest and debt expense(2)(1)(1)(1)(2)(2)(3)
Income (loss) from continuing operations before equity method investments, income taxes:(153)(23)73(21)82(14)
Other undisclosed income (loss) from continuing operations before income taxes109     (4)
Income (loss) from continuing operations before income taxes:(44)(23)73(21)82(18)
Income tax expense (benefit)232(1)8011
Net income (loss) available to common stockholders, basic:(42)(20)76(22)153(7)
Interest on convertible debt  2  2 
Net income (loss) available to common stockholders, diluted:(42)(20)77(22)155(7)

Comprehensive Income ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net income (loss):(42)(20)76(22)153(7)
Comprehensive income (loss):(42)(20)76(22)153(7)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(0)(0)(0)(0)(0)3
Comprehensive income (loss), net of tax, attributable to parent:(42)(20)76(22)153(4)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: